Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Semiconductor tariff to post big challenge to Taiwan: Think tank
08/02/2025 02:24 PM - Politics
AmCham urges U.S., Taiwan to resolve tariff uncertainty
08/02/2025 01:31 PM - Society
Heavy rain advisory issued for 18 areas in Taiwan: CWA
08/02/2025 01:10 PM - Society
Heavy downpour triggers widespread flooding in Tainan
08/02/2025 12:49 PM - Society
Taiwan headline news
08/02/2025 12:34 PM